Comparing Health Spending Across States And OECD Economies
Health spending per capita offers a straightforward way to compare the resources devoted to medical care, but the figure requires careful interpretation. A high amount may reflect expensive prices, an older population, greater use of specialist services, broader insurance coverage, or a combination of these factors. A lower amount may indicate efficiency, limited access, lower prices, or unmet medical needs.
Comparisons between US states and OECD nations are especially useful because they reveal two different dimensions of the same health system. OECD statistics place the United States beside other wealthy countries, while state-level records show how spending varies within the country. Massachusetts, Utah, Alaska, and other states can operate in very different economic and demographic environments while sharing federal programs, national pharmaceutical markets, and common payment rules.
Open government data makes this analysis more transparent. Publicspending.net’s datasets, standardized records, downloadable files, and query tools can help researchers move from broad averages to individual jurisdictions, spending categories, agencies, and payment patterns. The strongest findings come from combining those records with national health expenditure and OECD accounts rather than treating one number as a complete measure of performance.
What Health Spending Per Capita Actually Measures
Per-capita health expenditure is calculated by dividing total health spending by the population. It can include hospital care, physician services, prescription medicines, nursing and residential care, public health programs, dental services, and administrative costs. The exact boundaries depend on the statistical system behind the figure.
OECD comparisons generally use current health expenditure and purchasing power parity, or PPP, to make national costs more comparable. PPP adjusts for differences in the general price level between countries. US state estimates, by contrast, are often reported in current dollars and may use state-specific spending accounts. A direct ranking can therefore mix adjusted and unadjusted figures unless the methodology is made explicit.
A second distinction concerns the payer. “Total health spending” includes public programs, private insurance, employer contributions, and household payments. “Government health spending” covers a narrower portion, such as Medicaid, Medicare, state employee health benefits, public hospitals, or local health departments. These categories answer different questions and should not be merged.
The population denominator matters as well. A state with a large elderly population may spend more per resident because older adults use more medical services. A nation with a younger population may record a lower average while still providing extensive preventive or primary care. Per-capita spending is a useful starting point, not a complete measure of health system quality.
Why The United States Spends More Than The OECD Average
The United States has consistently ranked well above the OECD average in health expenditure per person. In recent OECD data, US current health spending has been roughly twice the average for high-income member countries when measured in PPP-adjusted dollars. The gap is driven less by unusually high utilization of every medical service than by the price of care, insurance administration, pharmaceuticals, specialist services, and hospital treatment.
Price differences are central. A hospital procedure, physician consultation, or prescription medicine can cost substantially more in the United States than in comparable economies. Higher prices raise total expenditure even when the number of visits or hospital days is similar. Private negotiations, fragmented purchasing, patent protections, labor costs, and regional market concentration all influence those prices.
The United States also combines public and private financing in a complex way. Medicare and Medicaid cover major portions of the population, while employer-sponsored insurance, individual plans, out-of-pocket payments, and uncompensated care add further layers. Administrative spending appears across insurers, providers, employers, and government agencies, making it difficult to identify a single source of excess cost.
OECD nations differ in how they organize universal coverage. Some rely on national health services, some use social insurance funds, and others combine public programs with regulated private coverage. Their per-capita totals may be lower because governments negotiate prices, standardize benefits, or use centralized purchasing. Lower spending does not automatically prove better performance, but it does highlight the scale of the US cost difference.
State Variation Inside The American System
The national US average conceals a wide range of state outcomes. Massachusetts and Alaska typically sit near the high end of per-person health spending, while states such as Utah often fall closer to the lower end. These differences reflect income, provider prices, population age, rural access, insurance coverage, chronic illness, and the availability of advanced medical facilities.
Massachusetts has a dense concentration of hospitals, teaching institutions, specialists, and biomedical organizations. Its residents also have relatively high insurance coverage and access to more intensive services. Those conditions can increase spending while supporting better access to care. Alaska faces a different set of pressures: long travel distances, remote communities, high operating costs, and limited provider supply can raise the price of delivering basic services.
Utah illustrates how a younger population and different utilization patterns can contribute to lower per-capita spending. A low average, however, should not be interpreted as proof that residents receive better value. The figure may also reflect fewer providers, delayed treatment, lower wages, or reduced access to expensive services.
State comparisons become more informative when spending is paired with outcomes and social indicators. Analysts can examine insurance coverage, avoidable hospitalizations, mortality, preventive care, primary-care availability, and household medical burden. A state that spends less but has serious access problems requires a different policy interpretation from a state that spends less while maintaining strong outcomes.
A Crosswalk Of Spending Benchmarks
The following figures illustrate the scale of the comparison rather than establish a definitive league table. OECD data are generally PPP-adjusted, while the state examples use nominal dollars from US state health expenditure estimates. Years and accounting definitions must be aligned before producing a formal ranking.
| Jurisdiction or benchmark | Approximate per-capita spending | Measurement context | What the figure suggests |
|---|---|---|---|
| OECD average | About $6,000 | Current health expenditure, PPP-adjusted, recent year | A broad high-income-country reference point |
| United States | About $12,500 | Current health expenditure, PPP-adjusted, recent OECD year | Spending is roughly twice the OECD average |
| Utah | About $8,500 | State personal health care spending, nominal dollars, recent estimate | Lower state spending, influenced by age and utilization patterns |
| Massachusetts | About $14,500 | State personal health care spending, nominal dollars, recent estimate | High spending associated with prices, specialists, and provider density |
| Alaska | About $13,500 | State personal health care spending, nominal dollars, recent estimate | High delivery costs and geographic barriers affect the total |
These amounts should be read as directional benchmarks. A state dollar is not equivalent to a PPP-adjusted international dollar, and a state personal health care account may exclude or classify administrative items differently from an OECD national account. A valid comparison requires common definitions, matching years, and careful treatment of population coverage.
The table still makes one important point visible: variation within the United States can be large enough to resemble the gap between the United States and other wealthy countries. State policy analysis therefore deserves the same attention given to international rankings.
How To Make The Comparison More Reliable
The first step is to establish a common spending concept. Researchers should decide whether they are measuring total health expenditure, public expenditure, personal health care, Medicaid spending, or another category. Mixing total national spending with state government payments creates a misleading result because the numerator does not describe the same financial activity.
The second step is to align the years. Health expenditure data can change quickly because of inflation, pandemic-related treatment, emergency funding, enrollment changes, and shifts in pharmaceutical prices. If one jurisdiction is represented by 2019 data and another by 2022 data, the comparison should state that limitation clearly.
Price adjustment also deserves attention. PPP is suitable for comparing purchasing power across countries, while inflation-adjusted constant dollars are useful for comparing one US state across time. Researchers should avoid applying a national PPP conversion to state spending without explaining the assumptions behind it.
Population adjustment can improve the analysis. Age-standardized spending helps separate demographic composition from differences in service use. Income, rurality, disability prevalence, disease burden, and insurance status can also be included in a regression or benchmarking model. These controls do not eliminate policy differences, but they reduce the risk of attributing every variation to efficiency.
What Open Spending Records Add
Published health expenditure accounts provide the broad totals, while open payment records can show how money moves through the system. Government transaction data may identify payments to hospitals, clinics, laboratories, pharmacies, universities, contractors, and public health organizations. That detail helps explain which institutions and programs contribute to a state’s spending profile.
Publicspending.net is particularly useful for exploratory work because it brings together standardized public payment data, downloadable datasets, graphs, and machine-readable access. Its SPARQL endpoint and ontology-based tools can support queries across agencies, recipients, locations, dates, and spending categories. Researchers can use those features to investigate patterns that disappear inside a statewide average.
Open records also make it easier to test public claims. An analyst can compare Medicaid-related payments across jurisdictions, identify unusually large contract recipients, track changes in hospital funding, or examine whether spending is concentrated in metropolitan areas. These records do not replace national accounts, because many private payments and insurance transactions are outside government datasets. They add institutional detail to the larger financial picture.
Data quality remains essential. Agency names may change, payment descriptions may be incomplete, duplicate records may occur, and fiscal years may not match calendar years. A responsible analysis documents the source, classification rules, exclusions, geographic definitions, and currency treatment. Reproducible queries and downloadable evidence make the resulting comparison easier to audit.
Recommendations For A Stronger Analysis
A useful cross-jurisdiction study should connect spending totals with the economic and institutional conditions that produce them. The following practices help keep the analysis accurate and policy-relevant:
- Use one clearly defined spending measure across all jurisdictions before calculating rankings.
- Separate government payments from total health expenditure, private insurance spending, and household out-of-pocket costs.
- Match years, adjust for inflation, and disclose whether international values use PPP.
- Pair per-capita spending with age, income, rurality, insurance coverage, and health outcome indicators.
- Use open payment records to investigate agencies, providers, contracts, and programs behind the aggregate totals.
The best comparisons also show uncertainty. A rounded estimate may be sufficient for a public-facing graph, while a policy paper may require source-level validation and sensitivity testing. Reporting a range, documenting revisions, and distinguishing observed payments from estimated expenditure can prevent false precision.
A practical workflow starts with OECD data for the international benchmark, US national accounts for context, and state-level expenditure records for internal variation. Publicspending.net can then provide a more granular layer for tracing public transactions and building repeatable queries. This combination supports both accessible communication and deeper research.
Use these sources to build a transparent view of health costs rather than a simple ranking. Explore the state and national datasets on Publicspending.net, compare definitions before comparing figures, and publish the calculations and queries that allow others to verify the result.